How did Tim Friede become immune to snake venom?
He injected himself with increasing doses of snake venom over time, allowing his body to develop antitoxin antibodies.
Yanuki
ARTICLE DETAIL
The Man Who Let Deadly Snakes Bite Him for 20 Years—And the Universal Antivenom Hiding in His Blood | Solar Impulse 2 Crashes in Gulf of Mexico After Military Testing | Deadly Asian Needle Ant Invasion: What You Need to Know | Moon Phase Today Explained: What the Moon Will Look Like on May 2, 2026 | Mysterious Earthquake Swarm Near Area 51 Sparks Conspiracy Theories | Aurora Forecast: Weekend Offers Glimpse of Northern Lights | Indigenous American Genome Reveals Complex History and Unique Diversity | AI Robot "Ace" Outplays Elite Table Tennis Players | Blue Origin's Satellite Launch Failure | The Man Who Let Deadly Snakes Bite Him for 20 Years—And the Universal Antivenom Hiding in His Blood | Solar Impulse 2 Crashes in Gulf of Mexico After Military Testing | Deadly Asian Needle Ant Invasion: What You Need to Know | Moon Phase Today Explained: What the Moon Will Look Like on May 2, 2026 | Mysterious Earthquake Swarm Near Area 51 Sparks Conspiracy Theories | Aurora Forecast: Weekend Offers Glimpse of Northern Lights | Indigenous American Genome Reveals Complex History and Unique Diversity | AI Robot "Ace" Outplays Elite Table Tennis Players | Blue Origin's Satellite Launch Failure
Science / Animals
The Man Who Let Deadly Snakes Bite Him for 20 Years—And the Universal Antivenom Hiding in His Blood
Tim Friede's unusual and dangerous dedication to science has led to a breakthrough in antivenom research. By intentionally exposing himself to the bites of numerous venomous snakes over two decades, Friede has developed a unique immune resp...
Key Insights
- Tim Friede has been bitten by over 200 snakes to develop immunity.
- His antibodies are being used to create a broad-spectrum antivenom by Centivax.
- The antivenom has shown full protection against 13 snake species and partial protection against six in mice trials.
- Clinical trials on dogs with snakebite injuries are planned in Australia.
- This research could revolutionize snakebite treatment, saving thousands of lives annually.
In-Depth Analysis
Tim Friede's journey began in 2001 with the goal of creating a better treatment for snakebites, which affect millions and cause numerous deaths and disabilities annually. Existing antivenoms, developed by injecting horses with venom, carry the risk of anaphylactic shock due to foreign equine proteins.
Friede started by injecting himself with diluted cobra venom, gradually increasing the concentration. He then progressed to live snake bites, facing near-fatal consequences, including a four-day coma after being bitten by cobras. Despite the risks and pain, Friede persisted, collaborating with scientists and undergoing numerous studies to understand his immune response.
Centivax, led by Jacob Glanville, extracted DNA from Friede's B-cells to clone his IgG antibodies. This led to the discovery that Friede's antibodies could neutralize venom from snakes he had never even been exposed to, such as the king cobra. The resulting antivenom cocktail, combining Friede’s antibodies with a toxin-blocking drug, has shown promising results in animal trials.
The next step involves testing the antivenom on dogs in Australia who have been brought in for snake bite injuries, with hopes of extending the treatment to viper bites. This research represents a significant advancement in snakebite treatment, potentially offering a more effective and safer alternative to traditional antivenoms.
FAQ
What is Centivax?
Centivax is a biotech company that is developing a universal antivenom based on Tim Friede's antibodies.
How effective is the new antivenom?
In mice trials, the antivenom provided full protection against 13 snake species and partial protection against six more.
Takeaways
- A universal antivenom could save thousands of lives each year by providing a more effective treatment for snakebites.
- Tim Friede's self-experimentation has paved the way for this breakthrough.
- Clinical trials are underway to test the antivenom on animals, with hopes of eventually using it in humans.
- The new antivenom may offer a safer alternative to traditional antivenoms, which can cause allergic reactions.
Discussion
Do you think this research will lead to a truly universal antivenom? Share your thoughts in the comments below!
Share this article with others who need to stay ahead of this trend!
Sources
Disclaimer
This article was compiled by Yanuki using publicly available data and trending information. The content may summarize or reference third-party sources that have not been independently verified. While we aim to provide timely and accurate insights, the information presented may be incomplete or outdated.
All content is provided for general informational purposes only and does not constitute financial, legal, or professional advice. Yanuki makes no representations or warranties regarding the reliability or completeness of the information.
This article may include links to external sources for further context. These links are provided for convenience only and do not imply endorsement.
Always do your own research (DYOR) before making any decisions based on the information presented.